BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 1724782)

  • 1. [Expression of keratin 16 in normal and lesional skin of solitary and multiple Bowen's disease using monoclonal antibody Ks 8.12 staining].
    Sheu HM; Ko SS; Yu HS
    J Formos Med Assoc; 1991 Dec; 90(12):1252-5. PubMed ID: 1724782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
    Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of basal cell keratin 14 expression in Bowen's disease: a possible marker for tumour progression.
    Komine M; Okinaga M; Takeda F; Nashiro K; Kikuchi K; Murakami T; Soma Y; Tamaki K
    Br J Dermatol; 2001 Aug; 145(2):223-8. PubMed ID: 11531783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of p2lWaf1/Cip1 immunohistochemical staining in Bowen's disease, but not in disseminated superficial porokeratosis.
    Kawakami T; Saito R; Takahashi K
    Br J Dermatol; 1999 Oct; 141(4):647-51. PubMed ID: 10583111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease.
    Kawakami T; Soma Y; Mizoguchi M; Saito R
    Dermatology; 2001; 202(1):9-15. PubMed ID: 11244221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma.
    Jang TJ
    Yonsei Med J; 2002 Jun; 43(3):304-8. PubMed ID: 12089736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies.
    Perkins W; Campbell I; Leigh IM; MacKie RM
    J Cutan Pathol; 1992 Dec; 19(6):476-82. PubMed ID: 1283171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of p16 and pRb expression with HPV detection in Bowen's disease.
    Willman JH; Heinz D; Golitz LE; Shroyer KR
    J Cutan Pathol; 2006 Sep; 33(9):629-33. PubMed ID: 16965338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered keratin expression in benign and malignant skin diseases revealed with monoclonal antibodies.
    Kariniemi AL; Virtanen I
    Am J Dermatopathol; 1989 Jun; 11(3):202-8. PubMed ID: 2471415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
    Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of keratins and involucrin in solar keratosis and Bowen's disease.
    Ichikawa E; Watanabe S; Otsuka F
    Am J Dermatopathol; 1995 Apr; 17(2):151-7. PubMed ID: 8600780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
    Hughes JH; Robinson RA
    Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nestin expression in Bowen's disease and Bowen's carcinoma associated with human papillomavirus.
    Mii S; Amoh Y; Tanabe K; Kitasato H; Sato Y; Katsuoka K
    Eur J Dermatol; 2011; 21(4):515-9. PubMed ID: 21700534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive alterations of cytokeratin expressions in the process of chronic arsenism.
    Yu HS; Chiou KS; Chen GS; Yang RC; Chang SF
    J Dermatol; 1993 Dec; 20(12):741-5. PubMed ID: 7509818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial spontaneous regression of Bowen's disease.
    Murata Y; Kumano K; Sashikata T
    Arch Dermatol; 1996 Apr; 132(4):429-32. PubMed ID: 8629847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry (S 100, KL 1) and human papillomavirus DNA hybridization on morbus Bowen and bowenoid papulosis.
    Hahn A; Löning T; Hoos A; Henke P
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(2):113-22. PubMed ID: 2455378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
    Ito T; Tsuji G; Ohno F; Nakahara T; Uchi H; Furue M
    Mod Pathol; 2017 Jul; 30(7):919-927. PubMed ID: 28339425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
    Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.